Intech Investment Management LLC Biomarin Pharmaceutical Inc Transaction History

Intech Investment Management LLC

$8.75 Billion
Q3 2024

A detailed history of Intech Investment Management LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Intech Investment Management LLC holds 53,856 shares of BMRN stock, worth $3.59 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

53,856

Previous 58,023 7.18%

Holding current value

$3.59 Million

Previous $4.78 Million 20.77%

% of portfolio

0.04%

Previous 0.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$69.02 - $93.84 $287,606 - $391,031	-4,167 Reduced 7.18%	53,856 $3.79 Million
Q2 2024 Aug 12, 2024	BUY	$74.43 - $92.22 $1.61 Million - $2 Million	21,669 Added 59.61%	58,023 $4.78 Million
Q1 2024 May 10, 2024	BUY	$83.81 - $99.0 $937,498 - $1.11 Million	11,186 Added 44.45%	36,354 $3.18 Million
Q4 2023 Oct 18, 2024	SELL	$76.22 - $98.51 $300,992 - $389,015	-3,949 Reduced 13.56%	25,168 $2.43 Million
Q4 2023 Feb 09, 2024	SELL	$76.22 - $98.51 $300,992 - $389,015	-3,949 Reduced 13.56%	25,168 $2.43 Million
Q3 2023 Oct 18, 2024	BUY	$85.07 - $94.48 $105,231 - $116,871	1,237 Added 4.44%	29,117 $2.58 Million
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $243,385 - $270,307	-2,861 Reduced 8.95%	29,117 $2.58 Million
Q2 2023 Oct 18, 2024	BUY	$86.68 - $100.3 $306,587 - $354,761	3,537 Added 14.53%	27,880 $2.42 Million
Q2 2023 Aug 09, 2023	BUY	$86.68 - $100.3 $403,582 - $466,996	4,656 Added 17.04%	31,978 $2.77 Million
Q1 2023 Oct 18, 2024	SELL	$87.74 - $117.27 $2.96 Million - $3.95 Million	-33,680 Reduced 58.05%	24,343 $2.37 Million
Q1 2023 May 10, 2023	BUY	$87.74 - $117.27 $1.09 Million - $1.46 Million	12,413 Added 83.26%	27,322 $2.66 Million
Q4 2022 Oct 18, 2024	BUY	$80.93 - $108.63 $57,136 - $76,692	706 Added 5.39%	13,804 $1.43 Million
Q4 2022 Feb 09, 2023	BUY	$80.93 - $108.63 $146,564 - $196,728	1,811 Added 13.83%	14,909 $1.54 Million
Q3 2022 Oct 18, 2024	SELL	$82.16 - $96.94 $3.69 Million - $4.36 Million	-44,925 Reduced 77.43%	13,098 $1.11 Million
Q3 2022 Nov 10, 2022	SELL	$82.16 - $96.94 $914,522 - $1.08 Million	-11,131 Reduced 45.94%	13,098 $1.11 Million
Q2 2022 Aug 10, 2022	BUY	$71.48 - $86.85 $1.73 Million - $2.1 Million	24,229 New	24,229 $2.01 Million

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.

Account

Intech Investment Management LLC Biomarin Pharmaceutical Inc Transaction History